DB 1311 201

A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

Condition: Advanced/Metastatic Solid Tumors | Last Updated: 7 Nov 2025 | Status: Enrolling

View Full Study